This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Fumiharu Yokoyama: Innovator in Cancer Treatment
Introduction
Fumiharu Yokoyama is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medicine, particularly in the development of treatments for malignant tumors. His innovative approach and dedication to research have led to the creation of a unique compound that holds promise for cancer therapy.
Latest Patents
Yokoyama holds a patent for a compound known as 5-methyl-6-phenyl-4,5-dihydro-2H-pyridazin-3-one derivative. This invention provides an agent for treating malignant tumors, comprising a compound of formula (1). His work in this area reflects his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Fumiharu Yokoyama is associated with Otsuka Pharmaceutical Company, Limited, where he has been able to apply his expertise in a collaborative environment. His role at the company has allowed him to focus on innovative research and development in pharmaceuticals.
Collaborations
Yokoyama has worked alongside talented colleagues such as Yuki Terauchi and Masatoshi Iida. Their combined efforts in research have contributed to the advancement of new therapeutic agents.
Conclusion
Fumiharu Yokoyama's contributions to cancer treatment through his innovative patent demonstrate his significant role in the pharmaceutical industry. His work continues to inspire advancements in medical research and treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile